@inproceedings{inproceedings, title  = {{171 Prevalence of a nice-defined indication for inclisiran in a real-world trans-pandemic acute coronary syndrome cohort}},

 publisher = {{BMJ Publishing Group Ltd and British Cardiovascular Society}},

 url = {{http://dx.doi.org/10.1136/heartjnl-2022-bcs.171 }},

 year = {{2022}},

 month = {{6}},

 author = {{Shaji N and Elamin N and Nelson T and Varian F and Storey R and Parker W}},

 doi = {{10.1136/heartjnl-2022-bcs.171}},

 journal = {{Stable IHD/Prevention/Hypertension/Lipids}},

 note = {{Accessed on 2024/12/22}}}